Jonathan Paul Shepherd

Publications

98 publications

Page 10 of 10

A systematic review of the cost-effectiveness of peginterferon alfa-2b in the treatment of chronic hepatitis C

Jonathan Shepherd & Jeremy Jones, 2007, Expert Review of Pharmacoeconomics & Outcomes Research, 7(6), 577-595

Type: article

Setting the future policy agenda for health technology assessment: a specialty mapping approach

Jonathan Shepherd, Jackie Briggs, Liz Payne, Claire Packer, Lynn Kerridge & Martin Ashton-Key, 2007, International Journal of Technology Assessment in Health Care, 23(4), 405-413

DOI: 10.1017/S0266462307070638

Type: article

Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation

J. Shepherd, J. Jones, D. Hartwell, P. Davidson, A. R. Price & N. Waugh, 2007, Health Technology Assessment, 11(11), 1-205

DOI: 10.3310/hta11110

Type: article

A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B.

A. Takeda, J. Jones, J. Shepherd, P. Davidson & A. Price, 2007, Journal of Viral Hepatitis, 14(2), 75-88

DOI: 10.1111/j.1365-2893.2006.00808.x

Type: article

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation

J. Shepherd, J. Jones, A. Takeda, P. Davidson & A. Price, 2006, Health Technology Assessment, 10(28), 1-183

DOI: 10.3310/hta10280

Type: article

Clinical- and cost-effectiveness of pegylated interferon alfa in the treatment of chronic hepatitis C: A systematic review and economic evaluation

Jonathan Shepherd, Håkan F.T. Brodin, Carolyn Backer Cave, Norman R. Waugh, Alison Price & John Gabbay, 2005, International Journal of Technology Assessment in Health Care, 21(1), 47-54

DOI: 10.1017/S0266462305050063

Type: article

Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults

C. Green, J. Dinnes, A. Takeda, J. Shepherd, D. Hartwell, C. Cave, E. Payne & B.H. Cuthbertson, 2005, Health Technology Assessment, 9(11)

DOI: 10.3310/hta9110

Type: article

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation

J. Shepherd, H. Brodin, C. Cave, N. Waugh, A. Price & J. Gabbay, 2004, Health Technology Assessment, 8(39), 1-140

Type: article

Dr Jonathan Shepherd

Connect with Jonathan

Publications

External roles and responsibilities